FDA, Clinical Trial News: $ABIO, $GENZ, $KV-A, $SLXP

Shares of ARCA Biopharma (NASDAQ:ABIO) are soaring today on news of an issued patent that includes the methods of treating heart failure patients with Gencaro (bucindolol) based on genetic testing.

Read more »